HINDUNILVR Q2 FY27 Results & Earnings Analysis
Sentiment: Good (Confidence: high)
Earnings Summary
HUL delivered strong Q2 FY27 results with 15% USG (highest in 14 quarters) and 7% UVG, driven by broad-based growth across Home Care (22% USG), Beauty & Wellbeing (16% USG), Personal Care (9% USG), and Foods (9% USG). Turnover was Rs. 18,071 crores with PAT bei growing 9% to Rs. 2,795 crores . EBITDA margin at 22.6% remained within guided 22-24% range despite ~400 bps gross margin compression from commodity inflation . Management maintained confident outlook on demand resilience, rural recovery, and premiumisation strategy, while acknowledging near-term inflation pressures and some volume rebalancing may occur . Interim dividend of Rs. 19/share declared . Key investor considerations: margin recovery timing, sustainability of volume growth amid pricing actions, and progress on 'Winning In New India' strategy execution .
Management Tone
- Prepared Remarks: Good — Prepared remarks emphasized strong broad-based growth, market share gains, strategic progress on 'Winning In New India' strategy, and confidence in medium-term outlook with EBITDA margin guidance of 22-24% . Management highlighted highest USG in 14 quarters and volume-led growth.
- Q&A Session: Neutral — Analysts pressed on gross margin contraction of ~400 bps YoY, weak Lifebuoy performance, Home Care margin lag, low ad-spend-to-sales ratio, and sustainability of volume growth amid pricing actions . Management responses were mostly direct but acknowledged cyclicity, lag effects in Home Care, and som
Revenue Growth Drivers
- Broad-based volume growth across segments and channels
- Calibrated price increases to cover absolute cost inflation
- Premiumisation and portfolio transformation (Home Care 22% USG, B&W 16% USG)
Growth vs Margin Focus
Management emphasized strategy of 'competitive, volume-led revenue and profit growth' . Prioritized volume growth by passing on absolute costs rather than maximizing margins, stating 'you can recover margin in a hurry. You don't recover market share and growth in a hurry' . Medium-term EBITDA margin
About Hindustan Unilever Limited
Hindustan Unilever Limited (HINDUNILVR) is listed on NSE. View the latest earnings analysis, AI-powered insights, and sentiment data on StockMirror.